CroíValve was founded in 2016 and is headquartered in Dublin, Ireland. The company develops medical device solutions focused on treating tricuspid regurgitation, creating the DUO™ System, a minimally invasive transcatheter valve technology designed to support the function of the native tricuspid valve while preserving heart anatomy.
CroíValve has 48 total employees and secured $20 million in additional Series B funding, bringing the round total to $36 million from investors including BGF, The European Innovation Council, and MedTech Syndicates. The company has achieved FDA IDE approval and initiated an Early Feasibility Study for the DUO Tricuspid Coaptation Valve System, indicating advancing regulatory progress.
Recent Leadership News
On July 28, 2026, CroíValve announced the appointment of Jaime Wheeler as Chief Executive Officer, with Lucy O'Keeffe transitioning to Chief Operating Officer. Wheeler is a healthcare executive with more than 25 years of experience, previously serving as Senior Vice President of Global Clinical Affairs for Transcatheter Heart Valves at Edwards Lifesciences.
Facts compiled by Executive Moves from publicly available news and press releases on 5 September 2026. Spotted an inaccuracy? Email us and we'll review within 1 business day.
To upgrade to a Premium Profile reach out to us at info@executive-moves.com.
Are you on the CroíValve team?
This is a Light company page, auto-generated from public news coverage. Claim it to verify the company description, add logo and links, and control how your organisation is represented on Executive Moves.
Claim this company →
